Table 2 Further characteristics of patients with NSCLC (n = 27)
Characteristics | Staging | ||
|---|---|---|---|
Histologic diagnosis Squamous cell carcinoma Adenocarcinoma others | 9 (33%) 13 (48%) 5 (19%) | Stage(AJCC) | |
Ia | 6 (22%) | ||
Ib | 4 (15%) | ||
IIa | 3 (11%) | ||
IIb | 3 (11%) | ||
IIIa* | 5 (19%) | ||
IIIb* | 1 (3%) | ||
IV* | 5 (19%) | ||
Chemotherapy before or after RT | Tumor: | ||
T1a | 2 (7%) | ||
yes | 12 (45%) | T1b | 10 (37%) |
T2a | 5 (19%) | ||
no | 15 (55%) | T2b | 1 (3%) |
T3 | 4 (15%) | ||
T4 | 5 (19%) | ||
Comorbidity: | Lymphnodes | ||
N0 | 18 (67%) | ||
N1 | 5 (19%) | ||
Pulmonary disease (COPD) | 6 (22%) | ||
Cardiovascular disease | 7 (26%) | ||
Both | 12 (45%) | N2 | 3 (11%) |
None of the above | 2 (7%) | N3 | 1 (3%) |
Metastasis: | |||
M0 | 22 (82%) | ||
M1a | 1 (3%) | ||
M1b | 4 (15%) | ||